期刊文献+

羟乙基淀粉中环氧乙烷残留量检查的方法探究

下载PDF
导出
摘要 中分子羟乙基淀粉200/0.5是目前世界各国广泛应用于容量治疗和休克的血浆增量剂,由于结构和糖元接近,过敏性样反应发生率最低,近年评价较高,是一个副作用少、外科手术及危重病治疗中理想的血浆增量剂。在进行羟乙基化反应过程中使用了环氧乙烷。原料中有少量残留,故对环氧乙烷残留量以及羟乙基淀粉的质量控制进行探究。
出处 《内蒙古石油化工》 CAS 2008年第11期30-30,共1页 Inner Mongolia Petrochemical Industry
  • 相关文献

参考文献5

二级参考文献33

  • 1张友松,李广芬.变性淀粉在纺织工业中的应用[J].淀粉与淀粉糖,1994(1):10-17. 被引量:3
  • 2Treib J, Baron JF, Grauer MT, et al. An international view of hydroxyethyl starches[J]. Intensive Care Meal, 1999,25 (3) : 258 -268.
  • 3Jungheinrich C, Sauermann W, Bepperling F, et al. Volume efficacy and reduced influence on measures of coagulation using hydroxyethyl starch 130/0.4 (6%) with an optimised in vivo molecular weight in orthopaedic surgery: a randomised, double-blind study[J]. Drugs R D, 2004,5(1) : 1 - 9.
  • 4Sander O, Reinhart K, Hellmann AM. Equivalence of hydroxyethyl starch HES 130/0.4 and HES 200/0.5 for perioperative volume replacement in major gynaecological surgery [J]. Acta Anaesthesiol Scand,2003,47(9) : 1151 - 1158.
  • 5Treib J, Haass A, Pindur G, ct al. All medium starches are not the same: influence of the degree of hydroxyethyl substitution of hydroxyethyl starch on plasma volume, hemorrheologic conditions,and coagulation[J]. Transfusion, 1996,36(5) :450 - 455.
  • 6Treib J, Haass A, Pindur G, et al. HES 200/0.5 is not HES 200/0.5 Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch(HES) on hemorheology, coagulation and elimination kinetics [J].Thromb Hoemost, 1995,74(6) : 1452 - 1456.
  • 7Waitzinger J, Bepperling F, Pabst G. et al. Effect of a new hydroxyethyl starch(HES) specification(6% HES 130/0.4) on blood and plasma volumes after bleeding in 12 healthy male volunteers[Jj.Clin Drug Invest, 1999,17 ( 2 ) : 119 - 125.
  • 8Waitzinger J, Bepperling F, Pabst G, et al. Pharmacokinetics and tolerability of a new hydroxyethyl starch ( HES ) specification ( 6%HES130/0.4) after single-dose infusion of 6% or 10% solution in heahhy volunteers[J]. Clin Drug Invest, 1998,16(2) : 151 - 160.
  • 9Waitzinger J, Bepper]ing F, Pabst G, et al. Hydroxyethy] starch (HES) [ 130/0.41, a new HES specification : pharmaeokineties and safety after multiple infusions of 10% solution in healthy volunteers[J]. Orugs R O ,2003,4(3) : 149 - 157.
  • 10Leuschner J, Opitz J, Winkler A, et al. Tissue storage of ^14 C-labelled hydroxyethyl starch (HES) 130/0.4 and HES 200/0.5 after repeated intravenous administration to rats[J]. Drugs R D, 2003,4(6) :331 - 338.

共引文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部